| 13-Jun-2022 | Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology. | Goldberg, Richard M; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; André, Thierry; Sobrero, Alberto F; Lichtman, Stuart M; Benson, Al B; Punt, Cornelis J A; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C ; Zalcberg, John; Tabernero, Josep; Van Cutsem, Eric; Matheson, Alastair; de Gramont, Aimery |
| 4-Sep-2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. | Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D; Shi, Qian; Sommeijer, Dirkje W; Bokemeyer, Carsten; Díaz-Rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Fuchs, Charles S; Goldberg, Richard M; Hecht, J Randolph; Hoff, Paulo M; Hurwitz, Herbert; Kabbinavar, Fairooz F; Koopman, Miriam; Maughan, Timothy S; Punt, Cornelis J A; Saltz, Leonard; Schmoll, Hans-Joachim; Seymour, Matthew T; Tebbutt, Niall C ; Tournigand, Christophe; Van Cutsem, Eric; de Gramont, Aimery; Zalcberg, John R; Buyse, Marc |